The emergence of multi-drug resistance makes bacterial infection a major threat to public
health and economy. The formation of bacterial biofilms is one of the main reasons of …

Microbial biofilms are becoming increasingly difficult to treat in the medical setting due to
their intrinsic resistance to antibiotics. To combat this, several biofilm dispersal agents are …

Insufficient osseointegration and biofilm-associated bacterial infection are important
challenges for clinical application of titanium (Ti)-based implants. Here, we constructed …

Although new antibiofilm agents have been developed to prevent and eliminate pathogenic
biofilms, their widespread clinical use is hindered by poor biocompatibility and …

Bacterial biofilm related infections are ever growing issues for global medical community.
Traditional antibiotic therapy is usually ineffective for treating them because the bacteria …

Antibiotic therapy is the most powerful strategy for treating bacterial infections in clinic.
However, antibiotic resistance has become one of the biggest threats to public health …

Lung diseases, including COVID-19 and lung cancers, is a huge threat to human health.
However, for the treatment and diagnosis of various lung diseases, such as pneumonia …

Pseudomonas aeruginosa biofilms cause persistent and chronic infections, most known
clinically in cystic fibrosis (CF). Tobramycin (TOB) is a standard anti‐pseudomonal antibiotic; …

Biofilms are formed at interfaces by microorganisms, which congregate in microstructured
communities embedded in a self-produced extracellular polymeric substance (EPS). Biofilm …

Pseudomonas aeruginosa (PA) is an opportunistic human pathogen, which is involved in a
wide range of dangerous infections. It develops alarming resistances toward antibiotic …